Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P46
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.29% |
| Q3 2025 | 9.45% |
| Q2 2025 | 19.48% |
| Q1 2025 | -11.76% |
| Q4 2024 | 9.47% |
| Q3 2024 | -2.05% |
| Q2 2024 | -23.75% |
| Q1 2024 | 7.44% |
| Q4 2023 | 7.17% |
| Q3 2023 | -17.27% |
| Q2 2023 | 19.44% |
| Q1 2023 | -192.91% |
| Q4 2022 | 55.03% |
| Q3 2022 | 9.31% |
| Q2 2022 | -16.98% |
| Q1 2022 | 18.36% |
| Q4 2021 | -85.95% |
| Q3 2021 | 14.82% |
| Q2 2021 | -41.28% |
| Q1 2021 | 49.40% |
| Q4 2020 | -97.71% |
| Q3 2020 | 11.95% |
| Q2 2020 | -5.77% |
| Q1 2020 | -2.37% |
| Q4 2019 | -18.42% |
| Q3 2019 | 17.15% |
| Q2 2019 | -21.30% |
| Q1 2019 | 6.27% |
| Q4 2018 | -36.10% |
| Q3 2018 | -40.81% |
| Q2 2018 | 54.27% |
| Q1 2018 | -36.21% |
| Q4 2017 | -6.67% |
| Q3 2017 | -25.63% |
| Q2 2017 | 11.70% |
| Q1 2017 | -26.08% |
| Q4 2016 | 15.98% |
| Q3 2016 | 28.38% |
| Q2 2016 | -315.89% |
| Q1 2016 | 28.78% |